Lucid Diagnostics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 2018-05-30
- Employees
- 70
- Market Cap
- -
- Website
- http://www.luciddx.com
Clinical Trials
5
Active:0
Completed:3
Trial Phases
1 Phases
Not Applicable:4
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (100.0%)CLUE: CLinical Utility Study of EsoGuard
Not Applicable
Completed
- Conditions
- Esophagus AdenocarcinomaBarrett EsophagusBarretts Esophagus With Dysplasia
- First Posted Date
- 2023-09-08
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 566
- Registration Number
- NCT06030180
- Locations
- 🇺🇸
Arkansas Heartburn Treatment Center, Heber Springs, Arkansas, United States
🇺🇸Arvada West Family Medicine,, Arvada, Colorado, United States
🇺🇸Colorado Primary Healthcare, Littleton, Colorado, United States
Lucid Registry Study
Recruiting
- Conditions
- Barretts Esophagus With DysplasiaBarrett's Esophagus Without DysplasiaBarrett EsophagusEsophageal Adenocarcinoma
- First Posted Date
- 2023-07-28
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT05965999
- Locations
- 🇺🇸
LUCID DX, Lake Forest, California, United States
Clinical Utility of a Non Endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barrett's Esophagus in At Risk Population
Not Applicable
Completed
- Conditions
- Barrett Esophagus
- First Posted Date
- 2023-03-21
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT05778851
- Locations
- 🇺🇸
Lucid Diagnostics, New York, New York, United States
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
Not Applicable
Recruiting
- Conditions
- Barrett EsophagusBarretts Esophagus With DysplasiaEsophageal AdenocarcinomaBarrett's Esophagus Without Dysplasia
- First Posted Date
- 2020-03-05
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 470
- Registration Number
- NCT04295811
- Locations
- 🇳🇱
Lucid Investigative Site, Rotterdam, Netherlands
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
Not Applicable
Completed
- Conditions
- Barrett EsophagusBarretts Esophagus With DysplasiaBarrett's Esophagus Without DysplasiaEsophageal Adenocarcinoma
- First Posted Date
- 2020-03-03
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Lucid Diagnostics, Inc.
- Target Recruit Count
- 145
- Registration Number
- NCT04293458
- Locations
- 🇪🇸
Lucid Investigative Site, Zaragoza, Spain
News
No news found